Early trial of peanut patch for peanut allergy shows promiseNovember 14, 2017
Bottom Line: A skin patch that delivered a high dose of peanut protein reduced peanut sensitivity in children and adults with peanut allergy, findings that warrant a phase 3 trial.
Why The Research Is Interesting: Allergy immunotherapy exposes people to a controlled dose of the proteins that trigger allergies so they become less sensitive or no longer sensitive. Peanut immunotherapy with a pill isn't especially effective and carries the risk of triggering allergy just as eating a peanut would. Skin patch immunotherapy may have potential for more safely and effectively treating peanut allergy.
Who: 221 peanut-allergic patients (age 6-55 years)
When: Phase 2b trial: July 31, 2012 - July 31, 2014. Extension: Patients completing the trial participated in a 2-year extension using the most effective peanut-patch dose to assess efficacy for up to 36 months; extension study completed September 29, 2016.
What (Study Measures): The percentage of treatment responders in each group vs placebo patch after 12 months. Patients were considered treatment responders if it took 1,000 mg or more of peanut protein and/or 10-times the pretreatment amount of peanuts to trigger an allergic reaction.
How (Study Design): This was a phase 2b clinical trial that randomly assigned participants to a peanut patch containing 50 μg, 100 μg or 250 μg of peanut protein or placebo for 12 months. Phase 2b trials confirm the efficacy of an intervention and determine the most effective dose and are typically followed by a phase 3 trial in a broader population. Randomized clinical trials (RCTs) allow for the strongest inferences to be made about the true effect of an intervention such as a medication or a procedure. However, not all RCT results can be replicated in real-world settings because patient characteristics or other variables may differ from those that were studied in the RCT.
Authors: Hugh A. Sampson, M.D., Icahn School of Medicine at Mount Sinai, New York, and coauthors
Results: There were more treatment responders among patients given the 250-μg peanut patch (n = 28; 50 percent) than among patients given the placebo patch (n = 14; 25 percent). There was no difference between the placebo and 100-μg patch. The percentage of patients with one or more treatment-emergent adverse events (largely local skin reactions) was similar across all groups in year 1.
Study Limitations: The primary end point (10-times increase in challenge threshold) may not have been sufficiently stringent for the lowest food challenge doses, which contributed to the higher-than-expected rate of placebo responders. The sample size of each treatment group was relatively small and therefore, the study was not powered to detect a dose-response gradient.
Study Conclusions: These findings support testing of the 250-μg peanut patch dose in a phase 3 trial involving patients with peanut allergy.
From JAMA Pediatrics, the article, "Evolution of Guidelines on Peanut Allergy and Peanut Introduction in Infants."
For more details and to read the full study, please visit the For The Media website.
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Want to embed a link to this study in your story? Link will be live at the embargo time http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2017.16591
The JAMA Network Journals
Related Placebo Articles:
Feeling heartbroken from a recent breakup? Just believing you're doing something to help yourself get over your ex can influence brain regions associated with emotional regulation and lessen the perception of pain.
A new study published in Brain indicates that successful treatment for insomnia may not actually require complicated neurofeedback (direct training of brain functions).
Emergency patients treated with naproxen and placebo had outcomes as good as or better than patients treated with naproxen and diazepam (trade name Valium) for acute lower back pain, according to the results of a double-blind, randomized clinical trial published last week in Annals of Emergency Medicine ('Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain').
Researchers with the PRESERVE-1 Study Group University of Texas Health Science Center at Houston -- McGovern Medical School, Houston, Texas, and Yale School of Medicine, New Haven, Conn., present findings of a study titled Randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant Antithrombin versus placebo in preterm preeclampsia.
Exploiting the placebo effect significantly improved the recovery of patients undergoing heart surgery according to new research published in the open access journal BMC Medicine.
Scientists have identified for the first time the region in the brain responsible for the placebo effect in pain relief.
For patients with chronic back pain, 'open' treatment with placebo -- informing patients that they are taking an inactive pill, and why it might be helpful -- leads to reductions in pain and disability, reports a study in PAIN®, the official publication of the International Association for the Study of Pain.
This is the first study to demonstrate beneficial placebo effect for lower back pain sufferers who knew they were taking 'fake pills.' Patients who knowingly took placebos reported 30 percent less pain and 29 percent reduction in disability compared to control group.
Manual-therapy randomized controlled trials (RCTs) are difficult to perform because it's challenging to conceal a placebo when patients are able to physically feel a treatment that's being delivered.
A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data (1) presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.
Related Placebo Reading:
You Are the Placebo: Making Your Mind Matter
by Dr. Joe Dispenza (Author)
Is it possible to heal by thought alone—without drugs or surgery? The truth is that it happens more often than you might expect. In You Are the Placebo,Dr. Joe Dispenza shares numerous documented cases of those who reversed cancer, heart disease, depression, crippling arthritis, and even the tremors of Parkinson’s disease by believing in a placebo. Similarly, Dr. Joe tells of how others have gotten sick and even died the victims of a hex or voodoo curse—or after being misdiagnosed with a fatal illness. Belief can be so strong that pharmaceutical companies use double- and... View Details
Placebo: Mind over Matter in Modern Medicine
by Dylan Evans (Author)
Can we really cure ourselves of disease by the power of thought alone? Faith healers and alternative therapists are convinced that we can, but what does science say?
Contrary to public perception, orthodox medical opinion is remarkably confident about the healing powers of the mind. For the past fifty years, doctors have been taught that placebos such as sugar pills and water injections can relieve virtually any kind of medical condition. Yet placebos only work if you believe they work, so the medical confidence in the power of the placebo effect has provided scientific legitimacy to... View Details
Placebo Effects: Understanding the mechanisms in health and disease
by Fabrizio Benedetti (Author)
One of the most widespread words in medicine is placebo and placebo effect, although it is not always clear what it means exactly. Recent progress in biomedical research has allowed a better clarification of the placebo effect. We know that this is an active psychobiological phenomenon which takes place in the patient's brain and that is capable of influencing both the course of a disease and the response to a therapy.
Since publication of the first edition of this book in 2008, there has been an explosion of placebo research, and this new edition brings the topic fully up to date.... View Details
Placebo (The Jevin Banks Experience) (Volume 1)
by Steven James (Author)
While trying to debunk a controversial neurological research program, illusionist and filmmaker Jevin Banks uncovers a far-reaching conspiracy involving one of the world's largest pharmaceutical firms. View Details
by Howard O. Pittman (Author)
Webster's dictionary defines "placebo" as a "medication prescribed more for the mental relief of a patient than for the actual effect on his disorder, or something tending to sooth." The doctors tell us that if we know we are being treated with a placebo, it does not work. In our minds we must think that it is a real medication and has the strength or power to heal. If the patient believes this, then the treatment has been known to work wonders in many cases that otherwise could not have been treated. Placebo treatment is, in fact, nothing of substance, but in the mind of the patient it is... View Details
The Placebo: A Reader
by Franklin G. Miller (Editor), Luana Colloca (Editor), Robert A. Crouch (Editor), Ted J. Kaptchuk (Editor)
The placebo effect is a fascinating but elusive phenomena. Although no standard definition of the placebo effect exists, it is generally understood as consisting of responses of individuals to the psychosocial context of medical treatments or clinical encounters, as distinct from specific physiological effects of medical interventions. The Placebo is the first book to compile a selection of classic and contemporary published articles on the topic.
Systematic investigation of the placebo effect emerged in the 1950s in response to the development of randomized controlled... View Details
The Placebo Effect: An Interdisciplinary Exploration
by Anne Harrington (Author)
A mere "symbol" of medicine--the sugar pill, saline injection, doctor in a white lab coat--the placebo nonetheless sometimes produces "real" results. Medical science has largely managed its discomfort with this phenomenon by discounting the placebo effect, subtracting it as an impurity in its data through double-blind tests of new treatments and drugs. This book is committed to a different perspective--namely, that the placebo effect is a "real" entity in its own right, one that has much to teach us about how symbols, settings, and human relationships literally get under our... View Details
Placebo and Pain: From Bench to Bedside
by Luana Colloca (Editor), Magne Arve Flaten (Editor), Karin Meissner (Editor)
The placebo effect continues to fascinate scientists, scholars, and clinicians, resulting in an impressive amount of research, mainly in the field of pain. While recent experimental and clinical studies have unraveled salient aspects of the neurobiological substrates and clinical relevance of pain and placebo analgesia, an authoritative source remained lacking until now. By presenting and integrating a broad range of research, Placebo and Pain enhances readers’ knowledge about placebo and nocebo effects, reexamines the methodology of clinical trials, and improves the therapeutic... View Details
by Melissa James Gibson (Author)
You Are the Placebo Meditation 1 -- Revised Edition: Changing Two Beliefs and Perceptions
by Dr. Joe Dispenza (Author)
Dr. Joe Dispenza has created two meditation CDs—featuring different music—to accompany his book You Are the Placebo.
On this longer 56-minutedisc, Dr. Joewalks you through Meditation 1: Changing Two Beliefs and Perceptions. After introducing the open-focus technique, he then moves you into the practice of finding the present moment. When you discover the sweet spot of the present moment and you forget about yourself as the personality you have always been, you have access to other possibilities that already exist in the quantum field. That’s... View Details